×

Publications

Only a selection of our publications are published in English. Please visit stps.dk/udgivelser to acces all our publications.

  • Citizen and Patient Involvement Strategy

    | 03 May 2017 |

    The Danish Patient Safety Authority’s involvement strategy is a sub-strategy of the Authority’s organisation strategy. The involvement strategy supports the Authority's mission: We work fo

  • Learning Strategy

    | 30 September 2016 |

    The Danish Patient Safety Authority’s strategy for learning is an ancillary strategy subordinate to the Authority’s organisational strategy. The learning strategy supports both the Danish Patient S

  • Annual report human on tissues and cells 2011

    | 07 December 2012 |

    The annual report for human tissues and cells for 2011 has been prepared pursuant to the Danish Tissue Act and is based on reports submitted by tissue establishments and gynaecology clinics in Denmark in the period January to December 2011.

  • Annual report on human tissues and cells 2010

    | 28 October 2011 |

    The annual report for human tissues and cells for 2010 has been prepared pursuant to the Danish Tissue Act and is based on reports submitted by tissue establishments and gynaecology clinics in Denmark in the period January to December 2010.

  • Publication on medicines most frequently involved in serious adverse drug events

    | 12 October 2011 |

    A new study carried out by a working group associated with the Danish Medicines Agency's network "Prevention of Medication Errors" has shown that it is more or less the same groups of medicines that have been involved in the so-called adverse events from the 1970s and up until today. Based on the study, we have drawn up two lists of medicines that appear in high-risk situations – sorted by active substance and medicine group. The Danish Medicines Agency and the working group behind the study hope that these lists can become an important tool in the daily work with risks in the medication process in the health sector.

  • Report on the blood product area in 2010

    | 12 August 2011 |

    In 2010, 337.000 blood collections were made in Denmark. This is approximately 21.000 collections less than the previous year. Moreover, approximately 317.000 units of red blood cells (erythrocytes) were used in connection with blood transfusions in 2010.

  • Annual report on human tissues and cells 2009

    | 01 November 2010 |

    The Danish Medicines Agency's annual report on human tissues and cells has been prepared pursuant to the Danish Tissue Act and is based on reports submitted by the tissue establishments and gynaecology clinics in Denmark in the period January to December 2009.

  • Report on the blood product area in 2009

    | 17 August 2010 |

    In 2009, 358.000 blood collections were made in Denmark. This is approximately 4.000 collections more than the previous year. Moreover, approximately 332.000 units of red blood cells (erythrocytes) were used in connection with blood transfusions in 2009.

  • Annual report on human tissues and cells 2008

    | 05 March 2010 |

    The Danish Medicines Agency's annual report on human tissues and cells has been prepared pursuant to the Danish Tissue Act and is based on reports submitted by the tissue establisments and gynaecology clinics in Denmark in the period January to December 2008

  • Report on the blood product area in 2008

    | 02 September 2009 |

    The blood product report is published every year based on figures from the Danish blood centres and the Blood-donors in Denmark.

  • Report on the blood product area in 2007

    | 13 October 2008 |

    The blood product report is published every year based on figures from the Danish blood centres and the Blood-donors in Denmark.

  • Account of the blood product area in 2005

    | 21 September 2006 |

    The account contains figures about the collection of blood from donors and the use of the blood collected. The account is published annually based on figures from blood centres and the Blood-donors in Denmark.